市场调查报告书
商品编码
1486832
卵圆孔未闭 (PFO) 封堵器的全球市场 - 市场分析、竞争格局、市场预测 (2030)Patent Foramen Ovale (PFO) Closure Devices - Market Insights, Competitive Landscape and Market Forecast-2030 |
预计 2024 年至 2030 年预测期内,全球卵圆孔未闭 (PFO) 封堵器市场规模将以 5.46% 的复合年增长率成长。卵圆孔未闭(PFO)封堵器的需求主要是由于老年人口的增加和脑梗塞盛行率的增加而增加。此外,技术进步的不断进步促使全球新产品的开发和推出也是推动 2024-2030 年预测期内市场成长的主要因素。
卵圆孔未闭(PFO)封堵器的市场动态
根据世界卫生组织(WHO)2022年发布的数据,到2030年,全球六分之一的人将年龄在60岁或以上。此外,根据相同数据,60岁及以上的人口将从2020年的10亿增加到2050年的14亿。
根据联合国人口司的数据,到2050年,德国65岁及以上的人口预计将增加41%,达到2,400万,占总人口的近三分之一。随着年龄的增长,心臟会经历各种结构/功能变化,这是正常老化过程的一部分。这些变化会影响心血管系统,并可能导致卵圆孔未闭 (PFO) 的持续存在和发展。
因此,老年人口的增加预计将对卵圆孔未闭 (PFO) 封堵器市场的成长产生正面影响。
根据美国中风协会 (2021) 的数据,大约三分之一 (35%) 的缺血性中风被归类为隐性中风。此外,所有不明原因的中风有一半是栓塞性中风。因此,中风盛行率的上升产生了预防中风復发的需求,从而推动了卵圆孔未闭(PFO)封堵器市场的成长。
然而,有关设备併发症和长期安全性的担忧、与卵圆孔未闭 (PFO) 闭合设备和手术相关的高成本等,可能会限制市场成长。
卵圆孔(PFO)封堵器细分市场分析
在卵圆孔未闭(PFO) 封堵器市场的产品类型细分中,Amplatzer PFO 封堵器类别预计将在2023 年占据卵圆孔未闭(PFO) 封堵器市场的重要收入占有率。这是由于 Amplatzer PFO 封堵器设备提供的各种优势。该装置用于治疗与 PFO 相关的某些医疗状况,例如隐匿性中风和復发性偏头痛。 Amplatzer PFO 封堵器提供的主要优点之一是 Amplatzer PFO 封堵器的插入通常使用微创手术(例如经导管封堵器)进行。这种方法避免了心臟直视手术的需要,从而缩短了恢復时间并减少了术后併发症。此外,该装置的设计目的是有效地闭合卵圆孔,防止血栓和其他物质在心室之间通过,从而降低异常栓塞的风险,异常栓塞是马苏的潜在原因。因此,Amplatzer PFO 封堵器提供的各种优势预计将有助于该细分市场的成长。
此外,随着该细分市场需求的增长,市场公司向市场推出了各种新产品。例如,2022年9月,雅培在欧洲市场推出Amplatzer(TM) Talisman(TM) PFO封堵系统,用于治疗卵圆孔未闭(PFO)患者。
因此,由于上述因素,Amplatzer PFO 封堵器预计将出现显着增长,从而推动整个卵圆孔未闭 (PFO) 封堵器市场在预测期内的增长。北美预计将主导整个卵圆孔未闭 (PFO) 封堵器市场
预计到 2023 年,北美将在所有地区中占据卵圆孔未闭 (PFO) 封堵器市场的最高占有率。这是由于该地区中风发病率不断增加。此外,技术进步、关键参与者的存在、老年人口的增加以及产品开发、上市和批准方面的高前景正在推动北美卵圆孔未闭(PFO)封堵器市场的成长。
本报告研究和分析了全球卵圆孔未闭 (PFO) 封堵器市场,提供市场规模和预测、驱动因素和课题、公司和产品概况等。
Patent Foramen Ovale Closure Device Market By Product Type (Amplatzer Pfo Occluder, Cardioform Septal Occluder, And Others), End-User (Hospitals And Ambulatory Surgical Centers), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing incidence of cryptogenic stroke and increasing technological advancement leading to new product development
The global Patent Foramen Ovale Closure Device Market is estimated to grow at a CAGR of 5.46% during the forecast period from 2024 to 2030. The demand for Patent Foramen Ovale Closure device is primarily being bolstered by the rising geriatric population and increasing incidence of cryptogenic stroke. Additionally, increasing technological advancement leading to new product development and launches across the globe, is another major factor that is contributing to the growth of the Patent Foramen Ovale Closure market during the forecast period from 2024-2030.
Patent Foramen Ovale Closure Device Market Dynamics:
As per the data provided by the World Health Organization 2022, by the year 2030, 1 in 6 people in the world will be aged 60 years or over. Further, according to the same source the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion and by 2050.
According to the UN Population Division, Germany's population aged 65 and older is projected to grow by 41 percent to 24 million by 2050, accounting for nearly one-third of the total population. As the age increases the heart undergoes various structural and functional changes as a part of the normal aging process. These changes can affect the cardiovascular system, potentially contributing to the persistence or development of a Patent Foramen Ovale.
Therefore, the rise in the geriatric population will positively influence the growth of the Patent Foramen Ovale (PFO) Closure Devices market.
According to the data provided by the American Stroke Association 2021, around one in three which accounts for (35%) ischemic strokes are classified as cryptogenic. Additionally, half of the cryptogenic strokes are embolic strokes, which have an unknown origin. Thus, the rising incidence of cryptogenic strokes will create a need for the prevention of recurrent cryptogenic strokes thus eventually boosting the growth of the Patent Foramen Ovale Closure Device market.
However, the complications and concerns associated with the long-term safety of the device and the high cost associated with the Patent Foreman Ovale Closure Devices and procedures are some of the key constraints that may limit the growth of the Patent Foramen Ovale Closure Device market.
Patent Foramen Ovale Closure Device Market Segment Analysis:
Patent Foramen Ovale Closure Device Market by product type (Amplatzer PFO Occluder, Cardioform Septal Occluder, and Others), End-users (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the Patent Foramen Ovale Closure Device market, the Amplatzer PFO Occluder category is estimated to amass a significant revenue share in the Patent Foramen Ovale Closure Device Market in 2023. This can be attributed to the various advantages provided by Amplatzer PFO Occluder devices. The device is used for the treatment of certain medical conditions associated with PFO, such as cryptogenic strokes and recurrent migraines. One of the major advantages provided by Amplatzer PFO Occluder devices is that the insertion of the Amplatzer PFO Occluder is typically performed using a minimally invasive procedure, such as transcatheter closure. This approach avoids the need for open-heart surgery, leading to shorter recovery times and reduced postoperative complications. Additionally, the device is designed to effectively close the PFO, preventing the passage of blood clots or other materials between the heart chambers, thus reducing the risk of paradoxical embolism, which is a potential cause of cryptogenic strokes. Therefore, the various advantages provided by the Amplatzer PFO Occluder device is expected to contribute to the growth of the segment.
Furthermore, as the demand for this segment grows, various novel products are launched by market players in the market. For example, in September 2022, Abbott launched its Amplatzer(TM) Talisman(TM) PFO Occlusion System in the European market for the treatment of patients suffering from patent foramen ovale (PFO).
Therefore, owing to the above-mentioned factors, the Amplatzer PFO Occluder is expected to register significant growth, thereby driving the growth of the overall Patent Foramen Ovale Closure Device market during the forecast period.
North America Is Expected To Dominate The Overall Patent Foramen Ovale Closure Device Market:
North America is expected to account for the highest proportion of the Patent Foramen Ovale Closure Device Market in 2023, out of all regions. This is due to the increasing incidence of cryptogenic strokes in the region. Additionally, rising technological advancements, the presence of major players, increasing geriatric population, and a highly potent market in terms of product development, launches, and approvals are some of the factors driving the growth of the Patent Foramen Ovale Closure Device Market in North America.
According to the data provided by the American College of Cardiology 2019, it was estimated that cryptogenic strokes accounted for 15-40% of all strokes. Additionally, approximately 795,000 individuals suffer from cryptogenic strokes every year in the United States. Thus, the rising incidence of cryptogenic strokes will create a need for the treatment and management of Patent Foramen Ovale, thus resulting in the positive growth of the Patent Foramen Ovale Closure Device Market in the United States, which will eventually propel the Patent Foramen Ovale Closure Device market in North America.
Further, key players present in the region, such as, Abbott, W. L. Gore & Associates, Inc., and Occlutech Holding AG are currently driving a wide range of initiatives, such as enhancing market access and distribution, making investments in research and development and inking strategic collaborations and partnerships, which will further contribute for the growth of the Circadian Rhythm Sleep Disorders treatment market in North America.
Therefore, the factors mentioned above, are some of the important factors that are thereby responsible for driving the overall market for Patent Foramen Ovale Closure Devices in North America during the forecast period.
Patent Foramen Ovale Closure Device Market Key Players:
Some of the key market players operating in the Patent Foramen Ovale Closure Device market include Abbott, W. L. Gore & Associates, Inc., Occlutech Holding AG, SMT, and Cardia Inc., Lepu Medical Technology(Beijing)Co.,Ltd., Lifetech Scientific, AGA Medical Corporation, pfm medical ag, and Starway Medical Technology Inc.
Recent Developmental Activities In The Patent Foramen Ovale Closure Device Market:
Key Takeaways From The Patent Foramen Ovale Closure Device Market Report Study
Target Audience Who Can Be Benefited From This Patent Foramen Ovale Closure Device Market Report Study
Frequently Asked Questions For The Patent Foramen Ovale Closure Device Market:
A Patent Foramen Ovale Closure Device is a medical device used to close a small hole called a foramen Ovale present between the upper two heart chambers (atria) in patients suffering from patent foramen Ovale.
The global Patent Foramen Ovale Closure Device Market is estimated to grow at a CAGR of 5.46% during the forecast period from 2024 to 2030.
The Patent Foramen Ovale Closure Device Market is slated to witness prosperity owing to factors such as the rising geriatric population and increasing incidence of cryptogenic stroke. Additionally, increasing technological advancement leading to new product development across the globe, are some of the other factors resulting in appreciable revenue growth in the Patent Foramen Ovale Closure Device Market during the forecast period (2024-2030).
Some of the key market players operating in the Patent Foramen Ovale Closure Device Market Abbott, W. L. Gore & Associates, Inc., Occlutech Holding AG, SMT, and Cardia Inc., Lepu Medical Technology(Beijing)Co.,Ltd., Lifetech Scientific, AGA Medical Corporation, pfm medical ag, and Starway Medical Technology Inc.
North America is expected to dominate the overall Patent Foramen Ovale Closure Device Market during the forecast period, 2024 to 2030. This can be ascribed to the presence of developed and sophisticated healthcare infrastructure, rising aging population, and increasing incidence of cryptogenic strokes in the region. Additionally, rising technological advancements, presence of major players, and a highly viable market in terms of product development, and launches are some of the factors driving the growth of the Patent Foramen Ovale Closure Device Market in North America.